During maintenance of anaesthesia, most anaesthetists prefer to use a carrier fresh gas flow (FGF) of 1.3 to 2.0 l.min -1 when using a Sword circle breathing system 1, 2 . Lowering FGF from medium flow (1 to 2 l.min -1 ) to low flow (500 to 1000 ml.min -1 ) or minimal flow (250 to 500 ml.min -1 ) has advantages such as reduced cost and increased gas humidification 3 . Even though these advantages of low FGF are well-recognised, anaesthesiologists seem hesitant to further reduce FGF, presumably because the resulting discrepancy that develops between the delivered (F D ) and inspired (F I ) concentration is perceived as "lack of control" 4 . In addition, the overwhelming administration tables in the appendix of Lowe and Ernst's work 5 and the initially rapidly decreasing uptake have led to the perception that frequent vaporiser and FGF changes are needed at the beginning of an anaesthetic when attention is often directed to completing other tasks. Lerou suggested that "a major problem is the lack of a simple dosing strategy that aids in attaining and maintaining predefined anaesthetic concentrations of inhaled anaesthetics" 4 . Although others have proposed simple administration regimens when using low FGF 6 , we sought to empirically develop a
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Derivation and prospective testing of a two-step sevoflurane-O 2 -N 2 O low fresh gas flow sequence T. van vaporiser setting -fresh gas flow (F D -FGF) sequence that would come close to "the ideal inductionmaintenance sequence", as defined by Mapleson 7 . The properties of an ideal F D -FGF sequence are economy, predictability and reproducibility, convenience and absence of unwanted gases.
To construct a F D -FGF sequence, most authors have first developed a model of the anaesthesia machine and the patient's body. They then consider mass balances in the system 4, 7, 8 . Instead, we opted to use an entirely empirical approach with a previously described "ideal O 2 -N 2 O FGF sequence" 9 consisting of a three-minute period of 6 l. 
MATERIAL AND METHODS

Part I: F D -FGF sequence derivation
After obtaining Institutional Review Board approval and written informed consent, 36 ASA physical status I or II patients presenting for plastic, urological or gynaecological surgery with an anticipated duration of at least 45 minutes were enrolled (n=18 for sequence derivation, n=18 for prospective testing). Patients weighing more than 95 kg were excluded.
All patients received oral alprazolam one hour before the scheduled start of surgery. After preoxygenation (8 l.min -1 O 2 FGF for three minutes), propofol (3 mg.kg -1 ), rocuronium (0.7 mg.kg -1 ) and sufentanil (0.1 µg.kg -1 ) were administered intravenously. After tracheal intubation, ventilation was mechanically controlled by an anaesthesia delivery unit anaesthesia machine (ADU, GE Healthcare, Helsinki, Finland). Ventilation tidal volume and respiratory rate were set fixed; the tidal volume at 500 ml and the respiratory rate at 9 to 12 breaths per minute (depending on patient weight). An initial period of high FGF of O 2 and N 2 O (2 and 4 l.min -1 , respectively) was followed by a total FGF of 0.7 l.min -1 (0.3 l.min -1 O 2 + 0.4 l.min -1 N 2 O) after three minutes. Sevoflurane and N 2 O administration were started simultaneously. The sevoflurane F D was adjusted to maintain F A sevo at 1.3%, starting with the maximum vaporiser output (8%) to maximise circuit and lung wash-in.
Inspiratory and expiratory gases were analysed by a multigas analyser (Datex-Ohmeda Compact Airway Module M-CAiOV, Datex-Ohmeda, Helsinki, Finland) and downloaded into a spreadsheet every 10 seconds. Vaporiser output was measured at the common gas outlet by the same gas analyser and compared with the dial setting using linear regression. Based on 233 measurements during this study, we calculated that measured sevoflurane vaporiser output (%) is equal to -0.03+1.04×dial setting (R 2 =0.971). Gases sampled by the multigas analyser (200 ml.min -1 ) were not redirected to the anaesthesia circuit because we wanted to develop a technique that does not require any equipment modifications. Any volume deficit of the bellows at end-expiration was measured as described previously 9 . Only data up to the first 45 minutes were included for analysis. Average F A sevo, F A N 2 O, F I O 2 , F I N 2 and bellows volume deficit over time for all the patients combined were calculated. F I N 2 was calculated as mass balance (100-F I sevoflurane-F I N 2 O-F I O 2 ). Visual inspection of the average F D pattern of all patients combined and knowledge of the duration to saturation of the vessel-rich group 10 was used to estimate how this curve could be approached by the least number of constant F D intervals. The average F D during these successive time intervals was then calculated and used as the values for the administration schedule tested in part II of the study. The average sevoflurane F D of the individual patients during these time intervals, as well as the maximum F D after the start of low FGF, were correlated by linear regression with the patients' age, height and weight. Unless specified otherwise, results are presented as mean (standard deviation).
Part II: Prospective testing
The management of these 18 patients did not differ from that described above, except for the application of the F D sequence derived in part I (see Results) . No other F D changes were allowed to be made. In both groups, additional sufentanil boluses were administered when tachycardia (heart rate >100 beats.min -1 ) or hypertension (mean arterial pressure>90 mmHg) ensued.
The performance of the F D -FGF sequence was analysed using Varvel's criteria 11 . The first 60 seconds were deleted from performance analysis because they represent system wash-in. Only data for the first 45 minutes were included in the analysis. Performance error (PE) was calculated as 100×(measured F A -predicted F A )/predicted F A . From PE, we calculated median PE (MDPE, in %, a measure of bias), median absolute PE (MDAPE, in %, a measure of accuracy), divergence (the slope of the linear regression equation of absolute values of PE against time for each subject, expressed in %.h -1 ; a time-related parameter that indicates how the inaccuracy of the administration schedule changes over time, with a positive value indicating a narrowing gap between predicted and measured F A and vice versa with a negative value) and wobble (median of [PE-MDPE] for each subject, expressed as a percentage; a measure of total intra-subject variability in PE, which is directly related to the ability of the schedule to achieve stable end-expired concentrations). Values of these parameters are expressed as median (25th; 75th percentiles). The average F A sevo of the individual patients during the derived time intervals as well as the minimum F A sevo after lowering FGF during these time intervals were correlated with the patients' age, height and weight by linear regression.
RESULTS
Part I: F D -FGF sequence derivation
Eighteen patients presented for plastic (n=6), urological (n=6) or gynaecological surgery (n=6). The study duration was 45 minutes in all but four patients (28, 30, 34 and 35 minutes). Age, height and weight were 47 (13) years, 168 (9) cm and 69 (15) kg; most patients were female (n=14). Sevoflurane F D and F A are presented in Figure 1A ; after an initial small overshoot (F A =1.62 [0.22] and 1.38 [0.13] after one and two minutes, respectively), sevoflurane F A was well maintained at 1.3%. F I O 2 , F A N 2 O and F I N 2 are presented in Figure 2A . Bellows volume changes did not interfere with ventilation in any patient. The maximum median bellows deficit was 13 ml (25th and 75th percentile 0 and 97 ml, respectively). In a 35-year-old, tall, athletic male patient (92 kg, 182 cm), high O 2 consumption led to a very rapid decrease in F I O 2 and rise in F A N 2 O (24.9% and 74.9%, respectively) with a bellows deficit that lingered at 884 ml after 25 minutes. This outlier explains the sudden change in standard deviation at 28 minutes of the F I O 2 and F A N 2 O values (Figure 2A) .
Three sevoflurane F D phases could be discerned ( Figure 1A) 
Part II: Prospective testing of the FGF-F D sequence
Another 18 patients presenting for plastic (n=5), urological (n=4), general (n=1) or gynaecological surgery (n=8) were enrolled to prospectively study the proposed sevoflurane-O 2 -N 2 O FGF sequence. The study duration was at least 30 minutes in all but three patients (25, 26 and 27 minutes) and at least 45 minutes in 10 patients. Age, height and weight were 44 (17) years, 167 (9) cm and 67 (12) kg; most patients were female (n=13). F I O 2 , F A N 2 O, and F I N 2 are presented in Figure 2B . Bellows volume changes did not interfere with ventilation except in one patient, for which FGF was temporarily increased to 0.4 l.min -1 O 2 + 0.6 l.min -1 N 2 O between 13 and 17 minutes. The maximum median bellows deficit was 13 (0; 156) ml. No F D adjustments were made. Sevoflurane F A was 1.13 (0.14)% after one minute, reaching 1.34 (0.12)% after two minutes and 40 seconds and falling to a nadir of 1.17 (0.10)% one minute and 20 seconds after lowering the FGF ( Figure 1A) ; after 15 minutes, F A had gradually increased to 1.38 (0.12)% and remained almost constant during the ensuing 25 minutes (1.32 (0.14)% after 40 minutes). MDPE (Figure 3 ) was 0.8 (-2.9; 5.9)%, MDAPE 6.7 (3.3; 10.6)%, divergence 18.2 (-5.6; 27.4)%.h -1 and wobble 4.4 (1.7; 8.1)%. No consistent correlations could be found between patient demographics and the average F A during any of the time intervals or the minimal F A during the three to 15 minute interval.
DISCUSSION
With the suggested FGF sequence, two sevoflurane vaporiser changes suffice to maintain anaesthetic gas concentrations with an ADU anaesthesia machine for at least 45 minutes within a sufficiently narrow range of the target concentration. The initial three-minute period represents wash-in of the circuit and lungs, as well as a brief period during which uptake in the blood and rapidly equilibrating tissues is starting to peak. suggested 2.6% during model derivation -the 2.6% value underestimates true F D values between three and nine minutes and overestimates them after nine minutes. This F A course is clinically desirable because the effects of the intravenous induction agents are still lingering, while the sevoflurane F A is still below target but increasing and because sevoflurane F A peaks at a time when surgical incision is most likely to occur. The use of a certain technique does not obviate the need for a vigilant anaesthetist and common sense. Therefore, if surgical stimulation occurs earlier than this, additional intravenous anaesthetics or a temporary but large increase in the vaporiser setting can be considered. Also, at any time during the anaesthetic, when a different sevoflurane F A is desired, the vaporiser setting can be adjusted. The number of F D -FGF combinations to achieve a particular target sevoflurane concentration is infinite, a concept outlined by Lowe and Ernst as "the anaesthetic continuum" 5 . Even though there are many possible pathways along the anaesthetic continuum to reach the same outcome, our emphasis was to find a simple sequence that was easy to remember and also economic. Indeed, we believe our sequence has particular appeal because it satisfies all four aspects of Mapleson's "ideal F D -FGF sequence": economics, reproducibility, convenience and reduced use and wastage of 'unwanted' gases.
First, it is economical. When low maintenance FGF is used, the initial high FGF period becomes a major determinant of vapour and gas consumption. The early FGF reduction (after three minutes) with the use of N 2 O is made possible by using the bellows volume in excess of tidal volume as a temporary reservoir of N 2 O and O 2 . The maintenance FGF of 0.7 l.min -1 is only slightly in excess of the sum of O 2 and N 2 O uptake and sampling, provides a margin for leaks and ensures N 2 concentrations remain low and actually decrease further during the anaesthetic. The combination of the shortest possible high FGF period plus the absence of a need for serial flushing to attenuate N 2 accumulation lowers agent consumption of the sequence below that of an automated end-expired closed-loop feedback closedcircuit administration 12 . Calculated consumption with our sequence is 5.11 ml liquid sevoflurane after 40 minutes. Fairly little can be gained by further lowering FGF because with the same anaesthesia machine sevoflurane uptake during closed circuit anaesthesia is 3.5 to 3.7 ml over the same time period 13, 14 . Administration regimens similar to ours can help steer more conventional anaesthesia machines to lower agent consumption similar to or below that of automated closed-loop feedback anaesthesia machines (such as the Zeus ®12 ), or could be used to improve administration algorithms of automated closed-loop feedback anaesthesia machines themselves.
Second, our sequence maintains the anaesthetic gas concentrations within a clinically acceptable (and safe) range of those predicted. The course of the O 2 and N 2 O concentrations has been consistent in five different patient groups, with the minimal (average) end-expired N 2 O concentration being at least 50% ( Figures 1A and B) 9,15 . A transient bellows volume deficit at end-expiration is unlikely to interfere with the delivery of the required tidal volume in the patients weighing less than 95 kg. For sevoflurane, the performance of our model (MDPE 0.8 [-2.9; 5.9]%, MDAPE 6.7 [3.3; 10.6]%,) is well within the limits deemed acceptable for target-controlled infusion systems (MDPE <10 to 20% and MDAPE 20 to 40%). Third, the sequence is clinically convenient: it is easily memorised and takes only seconds to implement without being distracting, even at the beginning of an anaesthetic. Baum 4 , which would only serve to increase agent consumption. Further lowering O 2 -N 2 O FGF would increase the complexity of the schedule and decrease its performance, while providing little additional economic gain.
The sequence also fulfils the final requirement of minimising the presence of the 'unwanted' gas by slowly eliminating N 2 .
Age, height and weight were found to be poor covariants during both model derivation and prospective testing, a finding corroborated by many uptake studies 13, 14, 17, 18 . The range of age, height and weight may not have been sufficiently wide to detect any correlation and we cannot exclude the possibility that non-linear correlations might be detected by more sophisticated statistical methods. The schedule also remains to be tested in a patient population that differs from that in our current study (e.g. we excluded patients weighing more than 95 kg) and with different anaesthesia machines with different rebreathing characteristics (e.g. without visible ascending bellows or without the capacity of using the bellows volume in excess of tidal volume as an additional reservoir). Even though these differences may necessitate slight adjustments in the described technique, the general principles outlined in this study should be broadly applicable. Certainly, anaesthetic agent monitoring should always be used to fine-tune the administration of agents in the individual patient regardless of the administration technique.
In summary, two sevoflurane vaporiser and one O 2 -N 2 O FGF change suffice to maintain satisfactory anaesthetic gas concentrations within a sufficiently narrow range with an ADU anaesthesia machine for at least 45 minutes. Gas monitoring and inspection of the position of the bellows at end-expiration are used to fine-tune the technique to the individual patient's needs and to the slow, gradual decrease in uptake.
This technique minimises anaesthetic waste to near-closed circuit anaesthesia conditions, yet is easily implemented in clinical practice. We believe that it approaches the ideal F D -FGF for sevoflurane in O 2 -N 2 O. Further prospective testing in different patient populations and with different anaesthesia machines may refine this technique and make it even more widely applicable.
There is no single optimal sequence; the number of sequences is infinite. Every sequence needs to be tested prospectively. We developed and tested one particular sequence that is easy to remember and administer, economical and reproducible.
